Clinical Trial Update: Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on paclitaxel and carboplatin with/without BMS-275291 in advanced or metastatic non-small cell lung cancer; trial phases 2 and 3 have comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BMS-275291
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED